Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-03-20, Stock:JNJ, The news for the past five days is as follows:
2020-03-13: NEWS1: CORRECTED-From $1 bln Musk trial to jury duty being put on hold, coronavirus hits U.S. courts.NEWS2: Americans rush to stock up on essentials as coronavirus spreads.NEWS3: There’s Still Time To Buy the Dip in Shopify Stock.NEWS4: Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio.NEWS5: Pharma Stock Roundup: ABBV, LLY Coronavirus Product Development Efforts, FDA Updates.NEWS6: Stocks With Generous Dividends Fell With Rest of Market.NEWS7: Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development.NEWS8: J&J says demand for consumer products higher due to coronavirus.NEWS9: This Medical Giant Was Socked In February — Is Its Stock A Safe Bet?.
2020-03-16: NEWS1: First human trial for coronavirus vaccine begins today: AP.NEWS2: Johnson & Johnson says no evidence HIV drug works against coronavirus.NEWS3: J&J Signs Another Collaboration to Develop Coronavirus Vaccine.
2020-03-17: NEWS1: Markets Are in Free Fall, but Don't Give in to Panic.NEWS2: Biopharma Expert Carston Thiel: 40%-60% of Socially Active People to Get Coronavirus.NEWS3: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results.NEWS4: Cost of inpatient coronavirus treatment could top $20k, study reveals.NEWS5: Calling A Bottom.
2020-03-18: NEWS1: Johnson & Johnson (JNJ) Stock Moves -1.19%: What You Should Know.NEWS2: Pharmaceutical Companies Gain in the Fight Against Covid-19.NEWS3: COVID-19 vaccine developer takes key step toward coronavirus trial in early summer.NEWS4: Johnson & Johnson (JNJ) Catches Eye: Stock Jumps 7.4%.NEWS5: Here’s one analyst’s take on the coronavirus drugs for today and the future.NEWS6: These 5 Mutual Funds Have Held Up.NEWS7: These Five Mutual Funds Have Held Up.NEWS8: These 13 companies are working on coronavirus treatments or vaccines — here’s where things stand.
2020-03-19: NEWS1: U.S. FDA says no scientific evidence that ibuprofen worsens coronavirus.NEWS2: My Top 10 Stock Watch List.NEWS3: Dow drops 186 points on losses for Coca-Cola, United Technologies stocks.NEWS4: Coca-Cola, Johnson & Johnson share losses lead Dow's nearly 100-point drop.NEWS5: J&J Files NDA for Multiple Sclerosis Drug Ponesimod in U.S..NEWS6: J&J stepping up Tylenol production as coronavirus boosts demand.NEWS7: The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection.

Answer: Decrease